CompletedNot Applicable

Drug Compliance and Affecting Factors in Juvenile Idiopathic Arthritis

Turkey (Türkiye)174 participantsStarted 2022-12-01

Plain-language summary

The goal of this observational study is to learn about the drug compliance of patients with juvenile idiopathic arthritis and, to figure our factors that affect the compliance. The main questions it aims to answer are: * Medication use and compliance in children with chronic diseases is an important problem, but do patients with JIA really use their medications in harmony? * Does the level of adherence to medications affect the quality of life of patients with JIA? Participants will be asked to fill the demographic form which includes personal information and nutritional habbits, Morisky Drug Compliance Scale - 8 and the pediatric quality of life inventory forms, with attending researcher Yesfa Sebnem Ozbay, M.D. This study is not an interventional study.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being followed up with the diagnosis of Juvenile Idiopathic Artritis (JIA) from the pediatric rheumatology outpatient clinic of Istanbul University, Istanbul Faculty of Medicine Exclusion Criteria: * Refusal of patients or their parents to participate in the study * Although the patient is followed up with the diagnosis of JIA, not using medication

What they're measuring

Drug Compliance by Morisky Medication Adherence Scale 8 (MMAS-8)

Timeframe: November 2022 - August 2023

Disease activation score

Timeframe: November 2022 - August 2023

PedsQL (Pediatric Quality of Life Inventory)

Timeframe: November 2022 - August 2023

Trial details

NCT IDNCT06000566

SponsorYesfa Sebnem Ozbay

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-01

View on ClinicalTrials.gov More Arthritis, Juvenile Rheumatoid trials